van Maanen JMS, Retel J, de Vries J, Pinedo HM: Mechanisms of action of antitumor drug etoposide: a review. J Natl CancerInst. 1998, 80: 1526-1533.
Article
Google Scholar
Hainsworth JD, Greco FA: Etoposide: Twenty years later. Annals Oncol. 1995, 6: 325-341.
CAS
Google Scholar
Hande KR: Clinical Oncology Update, Etoposide: Four decades of development of a topoisomerase II inhibitor. Eur J Cancer. 1998, 34 (10): 1514-1521.
Article
CAS
PubMed
Google Scholar
Markovits J, Pommier Y, Kerrigan D, Covey JM, Tilchen EJ, Kohn KW: Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and in the cell cycle in NIH-3T3 fibroblasts and L1210 leukemia cells. Cancer Res. 1987, 47: 2050-2055.
CAS
PubMed
Google Scholar
McPherson JP, Goldenberg GJ: Induction of apoptosis by deregulated expression of DNA topoisomerase IIL1. Can Res. 1998, 58: 4519-4524.
CAS
Google Scholar
Boos G, Stopper H: Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol Lett. 2000, 116: 7-16.
Article
CAS
PubMed
Google Scholar
Burden DA, Osheroff N: Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. BiochimBiophys Acta. 1998, 1400: 139-154.
CAS
Google Scholar
Wang JC: DNA topoisomerases. Ann Rev Biochem. 1996, 65: 635-692.
Article
CAS
PubMed
Google Scholar
Wang JC: Moving one DNA double helix through another by a type II DNA topoisomerase: The story of a simple molecular machine. Quart Rev Biophys. 1998, 31: 107-144.
Article
CAS
Google Scholar
Wang JC: Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol. 2002, 3: 430-440.
Article
CAS
PubMed
Google Scholar
Nitiss JL: Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim Biophys Acta. 1998, 1400 (1-3): 63-81.
Article
CAS
PubMed
Google Scholar
Fortune JM, Osheroff N: Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice. Prog Nucleic Acid Res Mol Biol. 2000, 64: 221-253.
Article
CAS
PubMed
Google Scholar
Bromber KD, Burgin AB, Osheroff N: A two drug model for etoposide action against human topoisomerase II. J Biol Chem. 2002, 277: 31201-31206.
Article
Google Scholar
Pommier Y, Fesen MR, Goldwasser F: Cancer chemotherapy and Biotherapy: Principles and practice. Edited by: Chabner BA, Longo DL. 1996, Lippincott-Raven Publishers, Philadelphia, 435-461. 2
Google Scholar
Li TK, Liu LF: Tumor cell death induced by topoisomerase-targeting drugs. Annu Rev Phamacol Toxicol. 2001, 41: 53-77.
Article
Google Scholar
Wilstermann AM, Osheroff N: Base excision repair intermediates as topoisomerase II poisons. J Biol Chem. 2001, 276: 17727-17731.
Article
CAS
PubMed
Google Scholar
Kreuzer KN, Cozarrelli NR: Escherichia coli mutants hermosensitive for deoxyribonucleic acid gyrase subunit A: effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth. J Bacteriol. 1979, 140: 424-435.
CAS
PubMed
PubMed Central
Google Scholar
Andoh T, Ishida R: Catalytic inhibitors of DNA topoisomerase II. Biochem Biophys Acta. 1998, 1400: 155-171.
CAS
PubMed
Google Scholar
Osheroff N: Effect of antineoplastic agents on the DNA cleavage/religation reaction of the eukaryotic topoisomerase II: inhibition of DNA relegation by etoposide. Biochemestry. 1989, 28: 6157-6160.
Article
CAS
Google Scholar
Robinson MJ, Osheroff N: Effects of antineoplastic drugs on the poststrand-passage DNA cleavage/religation equilibrium of topoisomerase II. Biochemistry. 1991, 30: 1807-1813.
Article
CAS
PubMed
Google Scholar
Long BH: Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16). Seminars in Oncology. 1992, 19: 3-19.
CAS
PubMed
Google Scholar
Kingma P, Osheroff N: The response of eukaryotic topoisomerases to DNA damage. Biochem Biophys Acta. 1998, 1400: 223-232.
CAS
PubMed
Google Scholar
Wang JC: DNA topoisomerases. Annu Rev Biochem. 1985, 54: 665-697.
Article
CAS
PubMed
Google Scholar
Pratt WB, Ruddon RW, Ensminger WD, Maybaum J: The anticancer drugs. 1996, Oxford University Press, New York
Google Scholar
van Maanem JM, Lafleur MV, Mans DR, Aker van den E, Ruiter C, Koostra PR, Pappie D, De Vries J, Retél J, Pinedo HM: Semiquinone formation from the catechol and ortho-quinone metabolites of the antitumor agent VP-16-213. Free Radic Res Commun. 1998, 4 (6): 371-84.
Article
Google Scholar
Kalyanaraman B, Nemec J, Sinha BK: Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR study. Biochemistry. 1989, 30: 4839-46.
Article
Google Scholar
Kagan VE, Yalowich JC, Day BW, Goldman R, Gantchev TG, Stoyanovsky DA: Ascorbate is the primary reductant of the phenoxyl radical of etoposide in the presence of thiols both in cell homogenates and in model systems. Biochemistry. 1994, 33: 9651-60.
Article
CAS
PubMed
Google Scholar
Walles SAS, Zhou R, Liliemark E: DNA damage induced by etoposide; a comparison of two different methods for determination of strand breaks in DNA. Cancer Lett. 1996, 105: 153-159.
Article
CAS
PubMed
Google Scholar
Rojas E, López MC, Valverde M: Single cell gel electrophoresis assay: methodology and applications. J Chromatography B. 1999, 722: 225-254.
Article
CAS
Google Scholar
Tice R, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki FC: Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000, 35: 206-221.
Article
CAS
PubMed
Google Scholar
Rogers SG, Weiss B: Cloning of the exonuclease III gene of Escherichia coli. Gene. 1980, 11: 187-195.
Article
CAS
PubMed
Google Scholar
Hartman A, Speit G: The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). ToxicolLett. 1997, 90 (2-3): 183-8.
Google Scholar
Rojas E, Valverde M, Kala SV, Kala G, Lieberman MW: Accumulation of DNA damage in the organs of mice deficient in γ-glutamyl transpeptidase. Mutat Res. 2000, 447: 305-316.
Article
CAS
PubMed
Google Scholar
Gedik CM, Boyle SP, Wood SG, Vaughan NJ, Collins AR: Oxidative stress in humans: validation of biomarkers of DNA damage. Carcinogenesis. 2002, 23 (9): 1441-1446.
Article
CAS
PubMed
Google Scholar
Cortés-Gutiérrez EI, Dávila-Rodríguez MI, López-Fernández C, Fernández JL, Gosálvez J: Alkali-labile sites in sperm cells from Sus and Ovis species. Int J Androl. 2008, 31 (3): 354-363.
Article
PubMed
Google Scholar
Sandri MI, Hochhauser D, Ayton P, Camplejohn RC, Whitehouse R, Turley H, Gatter K, Hickson ID, Harris AL: Differential expression of the topoisomerase II alpha and beta genes in human breast cancers. Br J Cancer. 1996, 73: 1518-1524.
Article
CAS
PubMed
PubMed Central
Google Scholar
Herzog CE, Holmes KA, Tuschong LM, Ganapathi R, Zwelling LA: Absence of topoisomerase IIβ in an amsacrine-resistant human leukemia cell line with mutant topoisomerase II α1. Canc Res. 1998, 58: 5298-5300.
CAS
Google Scholar
Negri C, Chiesa R, Cerino A, Bestagno M, Sala C, Zini N, Maraldi NM, Astaldi RG: Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170 and 180 kDa isozymes. Exp Cell Res. 1992, 200: 452-459.
Article
CAS
PubMed
Google Scholar
Stacey DW, Hitomi M, Chen G: Influence of cell cycle and oncogene activity upon topoisomerase IIα expression and drug toxicity. Mol Cell Biol. 2000, 20: 9127-9137.
Article
CAS
PubMed
PubMed Central
Google Scholar
Olive PL, Banath JP: Growth fraction measured using the comet assay. Cell Prolif. 1992, 25: 447-457.
Article
CAS
PubMed
Google Scholar
Fortini P, Raspaglio G, Falchi M, Dogliotti E: Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay. Mutagenesis. 1996, 11: 169-75.
Article
CAS
PubMed
Google Scholar
Horvátová E, Slamenová D, Hlinciková L, Kumar-Mandal T, Gábelová A, Collins AR: The nature and origin of DNA single-stranded breaks determined with the comet assay. Mut Res. 1998, 409: 163-171.
Article
Google Scholar
Ritov VB, Goldman R, Stoyanovsky DA, Menshikova EV, Kagan VE: Antioxidant paradoxes of phenolic compounds: peroxyl radical scavenger and lipid antioxidant, etoposide, inhibits sarcoplasmic reticulum Ca(2+)-ATPase via thiol oxidation by its phenoxyl radical. Arch Biochem Biophys. 1995, 321: 140-52.
Article
CAS
PubMed
Google Scholar
Tyurina YY, Tyurin VA, Yalowich JC, Quinn PJ, Claycamp HG, Schnor NF, Pitt BR, Kagan VE: Phenoxyl radicals of etoposide (VP-16) can directly oxidize intracellular thiols: protective versus damaging effects of phenolic antioxidants. Toxicol Appl Pharmacol. 1995, 131: 277-88.
Article
CAS
PubMed
Google Scholar
Gantchev TG, van Lier JE, Stoyanovsky DA, Yalowich JC, Kagan VE: Interactions of phenoxyl radical of antitumor drug, etoposide, with reductants in solution and in cell and nuclear homogenates: electron spins resonance and high-performance liquid chromatography. Methods in Enzymology. 1994, 234: 631-643.
Article
CAS
PubMed
Google Scholar
Tornov VA, Konoplyannikov MA, Nikolskaya TA, Konstantinov EM: Apoptosis of unstimulated human lymphocytes and DNA strand breaks in topoisomerase II inhibitor etoposide (VP16). Biochemistry. 1999, 64: 345-352.
Google Scholar
Prosperi E, Negri C, Marchese G, Ricotti GC: Expression of the 170-kDa and 180-kDa isoforms of DNA topoisomerase II in resting and proliferating human lymphocytes. Cell Prolif. 1994, 27: 257-267.
Article
CAS
PubMed
Google Scholar
Nouspikel T, Hanawalt PC: DNA repair in terminally differenciated cells. DNA repair. 2002, 1: 59-75.
Article
CAS
PubMed
Google Scholar
Wenzel U, Nickel A, Kuntz S, Daniel H: Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Carcinogenesis. 2004, 25 (5): 703-712.
Article
CAS
PubMed
Google Scholar
Liu WM, Oackley PR, Joel SP: Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines. Leukemia. 2002, 16: 1705-1712.
Article
CAS
PubMed
Google Scholar